Max Robotics — Global Service Robot Directory + US Certification

About

Tomohito Tanaka is a leading gynecologic oncologist whose research focuses on refining surgical approaches for early-stage cervical and endometrial cancers. His work centers on two critical, intertwined areas: comparing the oncologic safety of minimally invasive surgery (MIS) versus traditional abdominal radical hysterectomy (ARH), and advancing sentinel lymph node (SLN) biopsy techniques to reduce surgical morbidity without compromising survival. Tanaka’s most cited paper (2022, 8 citations) directly addresses the controversial finding that MIS may be associated with higher recurrence rates than ARH in cervical cancer, a study that has informed critical clinical decision-making. He further innovates by developing robot-assisted modified radical hysterectomy with lymphatic vessel removal using indocyanine green (ICG), a novel method (2022, 3 citations) designed to enhance the safety and precision of SLN procedures. His most recent work (2024, 2 citations) provides early oncologic outcomes for SLN biopsy in cervical cancer, a previously unreported area. Through these contributions, Tanaka is helping to define the optimal balance between surgical innovation and patient safety in gynecologic oncology.